PODCAST-19: FiveThirtyEight on the Novel Coronavirus
Een podcast door FiveThirtyEight, Anna Rothschild
46 Afleveringen
-
How To Vote Safely In A Pandemic
Gepubliceerd: 29-10-2020 -
Would Biden’s COVID-19 Plan Be Able To Control The Pandemic?
Gepubliceerd: 16-10-2020 -
The President Took A Rare Combo Of COVID-19 Drugs. Will It Help?
Gepubliceerd: 7-10-2020 -
The Significance Of Trump Testing Positive For COVID-19
Gepubliceerd: 2-10-2020 -
The New College Experience
Gepubliceerd: 26-9-2020 -
Can We Trust A Vaccine That Gets Approved?
Gepubliceerd: 19-9-2020 -
Why A Vaccine Trial Would Press Pause
Gepubliceerd: 12-9-2020 -
The U.S. Wants Out Of A Global Effort To Stop A Global Pandemic
Gepubliceerd: 4-9-2020 -
What's It Going To Take For Us To Become Immune?
Gepubliceerd: 28-8-2020 -
Russia Approved A COVID Vaccine. Will It Be Available In America?
Gepubliceerd: 14-8-2020 -
PODCAST-19 Has The Week Off!
Gepubliceerd: 7-8-2020 -
Lab-Grown Antibodies Might Protect Essential Workers
Gepubliceerd: 31-7-2020 -
It's Harder to Get A COVID Test If You're Black Or Hispanic
Gepubliceerd: 24-7-2020 -
When Does A Pandemic Start To Erode Civil Liberties?
Gepubliceerd: 17-7-2020 -
Dr. Anthony Fauci Talks With PODCAST-19
Gepubliceerd: 9-7-2020 -
How To Convince People To Stop A Pandemic
Gepubliceerd: 3-7-2020 -
Do Masks Actually Work?
Gepubliceerd: 26-6-2020 -
Who Will Be First To Get A COVID Vaccine?
Gepubliceerd: 19-6-2020 -
The Case Of The Bogus Hydroxycholoroquine Study
Gepubliceerd: 12-6-2020 -
What It's Like To Be A Black Doctor And Nurse Right Now
Gepubliceerd: 5-6-2020
FiveThirtyEight's COVID-19 podcast is laser-focused on evidence. What do we know about the novel coronavirus, and what do we know we don't know? COVID-19 has pushed Americans into more uncertain territory than most have ever known. Our podcast helps listeners understand what they can be certain about, and what is still unknown. We investigate coronavirus mysteries, debate when it's safe to reopen the economy and keep track of the latest scientific developments on vaccines and treatments. We do it all with FiveThirtyEight's trademark blend of transparency and rigor.
